(Q34415609)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

LY503430: pharmacology, pharmacokinetics, and effects in rodent models of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

1 reference

1 reference

Michael J O'Neill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Tracey K Murray

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Michael P Clay

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Terry Lindstrom

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Charles R Yang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Eric S Nisenbaum

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

77-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment

11 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2005.TB00037.X

Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons.

21 January 2018

1 reference

12 December 2020

Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.

1 reference

12 December 2020

Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic acid (AMPA) receptors

1 reference

12 December 2020

A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke

1 reference

12 December 2020

Current perspectives on the development of non-biogenic amine-based antidepressants

1 reference

12 December 2020

Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro

1 reference

12 December 2020

Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro

1 reference

12 December 2020

LY392098, a novel AMPA receptor potentiator: electrophysiological studies in prefrontal cortical neurons

1 reference

12 December 2020

Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo

1 reference

12 December 2020

Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator.

1 reference

12 December 2020

Antidepressant-like actions of an AMPA receptor potentiator (LY392098).

1 reference

12 December 2020

Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.

1 reference

12 December 2020

Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment

1 reference

12 December 2020

GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons

1 reference

12 December 2020

Glutamatergic mechanisms in schizophrenia

1 reference

12 December 2020

MPTP: insights into parkinsonian neurodegeneration

1 reference

12 December 2020

An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study.

1 reference

12 December 2020

LY404187: a novel positive allosteric modulator of AMPA receptors

1 reference

12 December 2020

Neuroprotective and neurorestorative strategies for Parkinson's disease

1 reference

12 December 2020

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

1 reference

12 December 2020

Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain

1 reference

12 December 2020

LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.

1 reference

12 December 2020

Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus

1 reference

12 December 2020

Enhancement of antidepressant potency by a potentiator of AMPA receptors

1 reference

12 December 2020

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

1 reference

12 December 2020

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

1 reference

12 December 2020

Ampakines reduce methamphetamine-driven rotation and activate neocortex in a regionally selective fashion

1 reference

12 December 2020

Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo

1 reference

12 December 2020

Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease

1 reference

12 December 2020

Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors.

1 reference

12 December 2020

Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.

1 reference

12 December 2020

Structure and function of glutamate receptor ion channels

1 reference

12 December 2020

AMPA receptor modulators as cognitive enhancers

1 reference

12 December 2020

Structure and gating of the glutamate receptor ion channel

1 reference

12 December 2020

AMPA receptor potentiators for the treatment of CNS disorders

1 reference

12 December 2020

AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression

1 reference

12 December 2020

Identification of a site in glutamate receptor subunits that controls calcium permeability

1 reference

12 December 2020

Excitatory amino acid receptors in the vertebrate central nervous system

1 reference

12 December 2020

Animal models of parkinsonism using selective neurotoxins: clinical and basic implications.

1 reference

12 December 2020

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

1 reference

12 December 2020

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

12 December 2020

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

12 December 2020

Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions

1 reference

12 December 2020

Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo

1 reference

12 December 2020

Facilitation of glutamate receptors enhances memory

1 reference

12 December 2020

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

12 December 2020

Facilitation of glutamate receptors reverses an age-associated memory impairment in rats

1 reference

12 December 2020

GAP-43: an intrinsic determinant of neuronal development and plasticity

1 reference

12 December 2020

Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans.

1 reference

12 December 2020

Kinetics of nigral degeneration in a chronic model of MPTP-treated mice

1 reference

12 December 2020

The glutamatergic dysfunction hypothesis for schizophrenia

1 reference

12 December 2020

1 reference

12 December 2020

Schizophrenia and glutamatergic transmission

1 reference

12 December 2020

Facilitative effects of the ampakine CX516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance.

1 reference

12 December 2020

Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity.

1 reference

12 December 2020

The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn

1 reference

12 December 2020

10.1111/J.1527-3458.2005.TB00037.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867954%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

PubMed publication ID

15867954

1 reference